These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1306668

  • 21. Mania and tramadol-fluoxetine combination.
    Gonzalez-Pinto A, Imaz H, De Heredia JL, Gutierrez M, Micó JA.
    Am J Psychiatry; 2001 Jun; 158(6):964-5. PubMed ID: 11384912
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC, Besag FM, Santosh PJ, Murray ML.
    Drug Saf; 2004 Jun; 27(13):991-1000. PubMed ID: 15471506
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF.
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [Abstract] [Full Text] [Related]

  • 29. Use of selective serotonin reuptake inhibitors in childhood depression.
    Curtin F, Schulz P.
    Lancet; 1996 Oct; 364(9435):660; author reply 661. PubMed ID: 15325821
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antidepressants and drug interactions: prescriber beware.
    Morris MR.
    J Am Coll Health; 1999 Jan; 47(4):191-2. PubMed ID: 9919851
    [No Abstract] [Full Text] [Related]

  • 32. Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
    Perucca E, Marchioni E, Soragna D, Savoldi F.
    Mov Disord; 1997 Jul; 12(4):624-5. PubMed ID: 9251094
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia.
    Stedman CA, Begg EJ, Kennedy MA, Roberts R, Wilkinson TJ.
    Hum Psychopharmacol; 2002 Jun; 17(4):187-90. PubMed ID: 12404686
    [Abstract] [Full Text] [Related]

  • 37. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Baldwin D, Bullock T, Montgomery D, Montgomery S.
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
    [Abstract] [Full Text] [Related]

  • 38. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB.
    Biol Psychiatry; 1998 Jul 15; 44(2):77-87. PubMed ID: 9646889
    [Abstract] [Full Text] [Related]

  • 39. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
    Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ.
    Arch Gen Psychiatry; 2012 Jun 15; 69(6):580-7. PubMed ID: 22309973
    [Abstract] [Full Text] [Related]

  • 40. Exploring treatment alternatives: weekly dosing of fluoxetine for the continuation phase of major depressive disorder.
    Burke WJ, McArthur-Miller DA.
    J Clin Psychiatry; 2001 Jun 15; 62 Suppl 22():38-42. PubMed ID: 11599647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.